Total Payments
$13,186
2024 Payments
$1,654
Companies
54
Transactions
736
Medicare Patients
6,097
Medicare Billing
$450,237
Payment Breakdown by Category
Food & Beverage$13,076 (99.2%)
Education$110.27 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,076 | 734 | 99.2% |
| Education | $110.27 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $2,647 | 131 | $0 (2023) |
| ABBVIE INC. | $1,931 | 111 | $0 (2024) |
| Amgen Inc. | $1,200 | 60 | $0 (2024) |
| Gilead Sciences, Inc. | $858.83 | 40 | $0 (2024) |
| Lilly USA, LLC | $808.73 | 47 | $0 (2024) |
| Novo Nordisk Inc | $579.45 | 42 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $496.34 | 31 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $359.03 | 24 | $0 (2024) |
| PFIZER INC. | $320.32 | 27 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $302.24 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,654 | 90 | ABBVIE INC. ($292.72) |
| 2023 | $1,716 | 95 | ABBVIE INC. ($378.83) |
| 2022 | $2,377 | 132 | ABBVIE INC. ($664.84) |
| 2021 | $2,320 | 141 | Amarin Pharma Inc. ($445.50) |
| 2020 | $1,860 | 110 | Amarin Pharma Inc. ($703.13) |
| 2019 | $1,320 | 69 | Amarin Pharma Inc. ($412.01) |
| 2018 | $1,157 | 64 | Amarin Pharma Inc. ($277.36) |
| 2017 | $781.76 | 35 | Amarin Pharma Inc. ($436.23) |
All Payment Transactions
736 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: PAIN | ||||||
| 12/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: UROLOGY | ||||||
| 11/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.91 | General |
| 11/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: UROLOGY | ||||||
| 11/11/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Bone Health | ||||||
| 10/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.55 | General |
| 10/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: UROLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Diabetes Care | ||||||
| 09/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Oncology | ||||||
| 09/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $31.74 | General |
| Category: PAIN | ||||||
| 09/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.92 | General |
| 09/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.92 | General |
| 09/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: UROLOGY | ||||||
| 09/11/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Obesity | ||||||
| 09/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Bone Health | ||||||
| 08/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Cardio-renal | ||||||
| 08/27/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,467 | 2,605 | $273,961 | $114,669 |
| 2022 | 29 | 1,472 | 2,408 | $252,852 | $113,264 |
| 2021 | 29 | 1,814 | 2,608 | $257,504 | $128,952 |
| 2020 | 25 | 1,344 | 2,249 | $223,811 | $93,352 |
Total Patients
6,097
Total Services
9,870
Medicare Billing
$450,237
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 292 | 936 | $168,165 | $52,865 | 31.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 173 | 173 | $24,900 | $22,437 | 90.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $7,350 | $5,643 | 76.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 25 | 25 | $4,415 | $4,004 | 90.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 76 | 103 | $11,830 | $3,743 | 31.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 174 | 174 | $3,480 | $3,213 | 92.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 82 | 82 | $8,200 | $3,134 | 38.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 91 | 91 | $2,912 | $2,747 | 94.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 35 | 35 | $3,150 | $2,653 | 84.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $8,975 | $2,321 | 25.9% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 21 | 22 | $5,720 | $1,930 | 33.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 49 | 55 | $1,780 | $1,744 | 98.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 38 | 38 | $1,705 | $1,271 | 74.5% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2023 | 18 | 18 | $1,530 | $1,223 | 79.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 48 | 52 | $3,120 | $1,076 | 34.5% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 18 | 41 | $2,490 | $1,055 | 42.4% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 17 | 38 | $5,700 | $936.88 | 16.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 59 | 98 | $2,940 | $860.44 | 29.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 21 | $672.00 | $610.40 | 90.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 15 | 32 | $960.00 | $387.21 | 40.3% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 12 | 36 | $1,440 | $340.56 | 23.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 34 | 34 | $1,360 | $280.56 | 20.6% |
| J3411 | Injection, thiamine hcl, 100 mg | Office | 2023 | 14 | 30 | $420.00 | $57.28 | 13.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 13 | 113 | $141.25 | $40.85 | 28.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 64 | $160.00 | $33.89 | 21.2% |
About Dr. Christopher Kang, M.D
Dr. Christopher Kang, M.D is a Internal Medicine healthcare provider based in Johns Creek, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447226808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Kang, M.D has received a total of $13,186 in payments from pharmaceutical and medical device companies, with $1,654 received in 2024. These payments were reported across 736 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($13,076).
As a Medicare-enrolled provider, Kang has provided services to 6,097 Medicare beneficiaries, totaling 9,870 services with total Medicare billing of $450,237. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Hospitalist
- Location Johns Creek, GA
- Active Since 02/27/2006
- Last Updated 01/14/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1447226808
Products in Payments
- Vascepa (Drug) $2,647
- UBRELVY (Drug) $684.90
- LINZESS (Drug) $629.80
- EVENITY (Biological) $471.17
- Livalo (Drug) $463.22
- GEMTESA (Drug) $411.52
- Prolia (Biological) $406.09
- ZENPEP (Drug) $384.74
- QULIPTA (Drug) $382.21
- Ozempic (Drug) $343.31
- NURTEC ODT (Drug) $338.58
- EMGALITY (Drug) $334.40
- JARDIANCE (Drug) $317.17
- Aimovig (Biological) $303.76
- SOLIQUA 100/33 (Biological) $224.32
- Dayvigo (Drug) $190.80
- CHANTIX (Drug) $164.09
- FARXIGA (Drug) $153.65
- Kerendia (Drug) $147.65
- FREESTYLE LIBRE 3 (Device) $146.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Johns Creek
Kapil Bhatia, Md, MD
Internal Medicine — Payments: $28,289
Internal Medicine $28,289
Mrs. Syamala Erramilli, Md, MD
Internal Medicine — Payments: $4,088
Internal Medicine $4,088
Dr. Binh Nguyen, Md, MD
Internal Medicine — Payments: $531.10
Internal Medicine $531.10
Shen Chen
Internal Medicine — Payments: $337.22
Internal Medicine $337.22
Dr. Vivian Umeozulu, M.d, M.D
Internal Medicine — Payments: $250.00
Internal Medicine $250.00
Saraswathi Jampala, Md, MD
Internal Medicine — Payments: $134.18
Internal Medicine $134.18